RxDoctor Payments Data

Adam Waller, NP

Nurse Practitioner · West Frankfort, ILNPI 1508476615

Payments from drug & device makers

$832in general payments, 2019–2025

Across 48 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$188
  • Novo Nordisk$157
  • Lilly USA, LLC$120
  • Xeris Pharmaceuticals, Inc.$86
  • Exact Sciences$47
  • Lundbeck LLC$47
  • plus $187 from 9 others

What the payments were for

  • Food & beverage$832100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$832 in reported general payments places this provider in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$46,178
Medicare patients
99
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban155$72,854
JardianceEmpagliflozin66$39,844
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$23,669
OzempicSemaglutide24$22,549
MyrbetriqMirabegron51$17,714
FarxigaDapagliflozin Propanediol31$15,985
RybelsusSemaglutide15$13,917
XareltoRivaroxaban27$12,548
TrulicityDulaglutide12$11,835
ElmironPentosan Polysulfate Sodium11$11,649
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$8,959
LinzessLinaclotide16$8,255
JanuviaSitagliptin Phosphate14$6,611
TradjentaLinagliptin12$6,259
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen296$5,760

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Fiasp$157$39,87950 claims
AstraZenecaFarxiga$188$15,98531 claims
AbbVieLinzess, Creon$15$12,90829 claims
Lilly USA, LLCTrulicity$120$11,83512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in West Frankfort

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →